Abstract
Active immunization of follicular lymphoma patients with idiotypic vaccines elicits antigen-specific antibody responses, T-cell responses, and antitumor effects. We hypothesized that these vaccinated patients could generate tumor-specific immune responses, not only against idiotype, but also against other tumor-associated antigens (TAA) by a mechanism of epitope spreading. To identify potential antigens, a phage surface expressed cDNA library derived from primary tumor cells was screened with sera from idiotype-vaccinated patients. Consistent with our hypothesis, we identified two immunogenic peptides (FL-aa-7 and 18), unrelated to idiotype, which were recognized by postvaccine sera but not by prevaccine or normal human sera. These peptide sequences derived from the 5'-untranslated regions of the human GTPase, IMAP family member 7 gene (FL-aa-7) and an alternative reading frame of U1-snRNP 70 (FL-aa-18), respectively, suggesting that epitope spreading had occurred.
References
Feb 1, 1990·Clinical Immunology and Immunopathology·E W St ClairD S Pisetsky
Oct 1, 1980·The Journal of Infectious Diseases·M D TolpinS A Plotkin
Aug 1, 1993·The Journal of Experimental Medicine·V BrichardT Boon
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·U SahinM Pfreundschuh
Jun 1, 1996·The Journal of Experimental Medicine·D BrändleB Van den Eynde
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Aug 29, 1997·The Journal of Experimental Medicine·S MandruzzatoP van der Bruggen
Feb 7, 1998·The Journal of Experimental Medicine·E JägerA Knuth
May 20, 1999·The Journal of Experimental Medicine·R F WangS A Rosenberg
Sep 30, 1999·Nature Medicine·M BendandiL W Kwak
Aug 10, 2000·Proceedings of the National Academy of Sciences of the United States of America·C D WolfgangI Pastan
Apr 27, 2001·Trends in Immunology·R F Wang
Nov 7, 2001·The Journal of Experimental Medicine·H KaoO J Finn
Mar 21, 2002·Journal of Internal Medicine·S A Rosenberg
May 16, 2002·Journal of Immunological Methods·Ping TsuiRaymond W Sweet
Nov 20, 2002·Cancer Immunology, Immunotherapy : CII·Shaoming HuangMichael Pfreundschuh
Dec 24, 2002·Nature Biotechnology·Paul J MintzWadih Arap
Sep 11, 2004·Journal of Clinical Immunology·Mary L DisisKeith L Knutson
Oct 12, 2004·Gene·Jürgen KrückenFrank Wunderlich
Sep 24, 2005·The New England Journal of Medicine·Xiaoju WangArul M Chinnaiyan